The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Acute-on-Chronic Liver Failure: Pathophysiological Basis of Therapeutic Options
Abstract
The vast majority of patients that are referred to a specialist hepatological centre suffer from acute deterioration of their chronic liver disease. Yet, this entity of acute-on-chronic liver failure remains poorly defined. With the emergence of newer liver support strategies, it has become necessary to define this entity, its pathophysiology and the short- and long-term prognosis. This review focusses upon how a precipitant such as an episode of gastrointestinal bleeding or sepsis may start a cascade of events that culminate in end-organ dysfunction and liver failure. We briefly review the pathophysiological basis of the therapeutic modalities that are available. Our current strategy for the management of liver failure involves supportive therapy for the end-organs with the hope that liver function would recover if sufficient time for such a recovery is allowed. Because liver failure, whether of the acute or acute-on-chronic variety, is potentially reversible, the stage is set for the application of newer liver-support strategies to enhance the recovery process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
Vallance, P., Collier, J., & Moncada, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91013-1 · Cited by 1,590
Galactosamine-induced sensitization to the lethal effects of endotoxin.
Galanos, C., Freudenberg, M. A., & Reutter, W. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.11.5939 · Cited by 929
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
Ginès, A., Escorsell, A., Ginès, P., Saló, J., Jiménez, W., Inglada, L., Navasa, M., Clària, J., Rimola, A., Arroyo, V., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90031-7 · Cited by 891
Bernard, B., Grangé, J.-D., Khac, E. N., Amiot, X., Opolon, P., & Poynard, T. (1999) · Hepatology · doi:10.1002/hep.510290608 · Cited by 836
Branched-Chain Amino Acid Metabolism
Yudkoff, M. (1999) · Cited by 762
Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score
de Mendonça, A., Vincent, J.-L., Suter, P. M., Moreno, R., Dearden, N. M., Antonelli, M., Takala, J., Sprung, C., & Cantraine, F. (2000) · Intensive Care Medicine · doi:10.1007/s001340051281 · Cited by 742
The systemic inflammatory response syndrome in acute liver failure
Rolando, N., Wade, J., Davalos, M., Wendon, J., Philpott-Howard, J., & Williams, R. (2000) · Hepatology · doi:10.1053/jhep.2000.17687 · Cited by 729
Self-citationSalter, M., Knowles, R. G., & Moncada, S. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81123-p · Cited by 630
Stange, Mitzner, Risler, Erley, Lauchart, Goehl, Klammt, S., Peszynski, Freytag, Hickstein, et al. (1999) · Artificial Organs · doi:10.1046/j.1525-1594.1999.06122.x · Cited by 604
Reversal of Type 1 Hepatorenal Syndrome With the Administration of Midodrine and Octreotide
Angeli, P., Volpin, R., Gerunda, G., Craighero, R., Roner, P., Merenda, R., Amodio, P., Sticca, A., Caregaro, L., Maffei-Faccioli, A., et al. (1999) · Hepatology · doi:10.1002/hep.510290629 · Cited by 564
Cited by
Moreau, R., Jalan, R., Gines, P., Pavesi, M., Angeli, P., Cordoba, J., Durand, F., Gustot, T., Saliba, F., Domenicali, M., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.042 · Cited by 3,020
Self-citationSarin, S. K., Kedarisetty, C. K., Abbas, Z., Amarapurkar, D., Bihari, C., Chan, A. C. Y., Chawla, Y. K., Dokmeci, A. K., Garg, H., Ghazinyan, H., et al. (2014) · Hepatology International · doi:10.1007/s12072-014-9580-2 · Cited by 1,481
“The hepatocellular injury in ACLF is driven to a large extent by a ‘‘cytokine burst,’’ with elevated levels of multitude of cytokines, small molecular weight toxins, vasoactive substances that are known to accumulate secondary to the failing liver [122].”
Arvaniti, V., D'Amico, G., Fede, G., Manousou, P., Tsochatzis, E., Pleguezuelo, M., & Burroughs, A. K. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.019 · Cited by 1,167
APASL ACLF Research Consortium (AARC) for APASL ACLF working Party., Sarin, S. K., Choudhury, A., Sharma, M. K., Maiwall, R., Al Mahtab, M., Rahman, S., Saigal, S., Saraf, N., Soin, A. S., et al. (2019) · Hepatology International · doi:10.1007/s12072-019-09946-3 · Cited by 884
Sarin, S. K., Kumar, A., Almeida, J. A., Chawla, Y. K., Fan, S. T., Garg, H., de Silva, H. J., Hamid, S. S., Jalan, R., Komolmit, P., et al. (2009) · Hepatology International · doi:10.1007/s12072-008-9106-x · Cited by 763
Self-citationAcute-on-Chronic Liver Failure
Arroyo, V., Moreau, R., & Jalan, R. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1914900 · Cited by 650
Self-citationAcute-on chronic liver failure
Jalan, R., Gines, P., Olson, J. C., Mookerjee, R. P., Moreau, R., Garcia-Tsao, G., Arroyo, V., & Kamath, P. S. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.026 · Cited by 646
Self-citationBañares, R., Nevens, F., Larsen, F. S., Jalan, R., Albillos, A., Dollinger, M., Saliba, F., Sauerbruch, T., Klammt, S., Ockenga, J., et al. (2013) · Hepatology · doi:10.1002/hep.26185 · Cited by 568
Self-citationAcute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis
Arroyo, V., Moreau, R., Jalan, R., & Ginès, P. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.045 · Cited by 451
Self-citationWu, T., Li, J., Shao, L., Xin, J., Jiang, L., Zhou, Q., Shi, D., Jiang, J., Sun, S., Jin, L., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314641 · Cited by 437
Acute-on-chronic liver failure in cirrhosis
Arroyo, V., Moreau, R., Kamath, P. S., Jalan, R., Ginès, P., Nevens, F., Fernández, J., To, U., García-Tsao, G., & Schnabl, B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.41 · Cited by 434
Self-citationEvidence-based clinical practice guidelines for Liver Cirrhosis 2020
Yoshiji, H., Nagoshi, S., Akahane, T., Asaoka, Y., Ueno, Y., Ogawa, K., Kawaguchi, T., Kurosaki, M., Sakaida, I., Shimizu, M., et al. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01788-x · Cited by 422
Kribben, A., Gerken, G., Haag, S., Herget–Rosenthal, S., Treichel, U., Betz, C., Sarrazin, C., Hoste, E., Van Vlierberghe, H., Escorsell, À., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.056 · Cited by 409
Jalan, R., Pavesi, M., Saliba, F., Amorós, A., Fernandez, J., Holland-Fischer, P., Sawhney, R., Mookerjee, R., Caraceni, P., Moreau, R., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.012 · Cited by 360
Self-citationOettl, K., & Stauber, R. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707251 · Cited by 357
Acute-on-chronic liver failure
Bernal, W., Jalan, R., Quaglia, A., Simpson, K., Wendon, J., & Burroughs, A. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00309-8 · Cited by 331
Self-citationEarly features of acute-on-chronic alcoholic liver failure: a prospective cohort study
Katoonizadeh, A., Laleman, W., Verslype, C., Wilmer, A., Maleux, G., Roskams, T., & Nevens, F. (2010) · Gut · doi:10.1136/gut.2009.189639 · Cited by 252
Mookerjee, R. P., Pavesi, M., Thomsen, K. L., Mehta, G., Macnaughtan, J., Bendtsen, F., Coenraad, M., Sperl, J., Gines, P., Moreau, R., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.018 · Cited by 248
Self-citationBeyond scoring: a modern interpretation of disease progression in chronic liver disease
Rosselli, M., MacNaughtan, J., Jalan, R., & Pinzani, M. (2013) · Gut · doi:10.1136/gutjnl-2012-302826 · Cited by 96
Self-citationSchacher, F. C., Martins Pezzi da Silva, A., Silla, L. M. D. R., & Álvares-da-Silva, M. R. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/3662776 · Cited by 54
Metadata
- Authors
- Jalan, R., & Williams, R.
- Venue
- Blood Purification
- Publisher
- S. Karger AG
- Published
- 2002
- Volume
- 20
- Issue
- 3
- Pages
- 252-261
- ISSN
- 0253-5068 (ISSN-L)
- 1421-9735
- OpenAlex
- W2088488647
- Cited by
- 286
- References
- 63
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.